Premium
Vaccines under study: non‐HIV vaccines
Author(s) -
Conner Kelly,
Wuu Alice,
Maldonado Victoria,
Bartlett Brenda L.,
Tyring Stephen K.
Publication year - 2009
Publication title -
dermatologic therapy
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.595
H-Index - 68
eISSN - 1529-8019
pISSN - 1396-0296
DOI - 10.1111/j.1529-8019.2009.01229.x
Subject(s) - medicine , licensure , human papillomavirus vaccine , virology , immunology , infectious disease (medical specialty) , hiv vaccine , human immunodeficiency virus (hiv) , disease , vaccine trial , cervical cancer , nursing , pathology , cancer , gardasil
The development of effective vaccines has been an amazing public health achievement and has resulted in countless lives being saved. Dermatologic therapy has recently been greatly advanced by the licensure of an effective human papillomavirus vaccine and herpes zoster vaccine. Despite these successes, many infectious diseases do not currently have a preventive vaccine. We review potential vaccines against selected infectious agents, including viruses, bacteria, fungi, and protozoa that have cutaneous and mucocutaneous manifestations. The road to licensure of a new vaccine begins with exhaustive preclinical and clinical studies, and many of these will fail before a successful vaccine candidate is approved. This article focuses on vaccines that have yet to be approved for licensure.